(Q40135888)

English

Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level.

scientific article published on 7 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Giovanni Di Maira

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Lorenzo A Pinna

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jessika Bertacchini

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Sandra Marmiroli

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Brustolon F

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Tosoni K

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

0 references

publication date

7 May 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

6915-6926

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

48

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210495

0 references

Targeting CK2 for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Joining the cell survival squad: an emerging role for protein kinase CK2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Promiscuous subunit interactions: A possible mechanism for the regulation of protein kinase CK2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Multidrug resistant proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Protein kinase CK2 phosphorylates and upregulates Akt/PKB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Differential Effect of HIV-1 Protease Inhibitors on P-Glycoprotein Function in Multidrug-Resistant Variants of the Human CD4+ T Lymphoblastoid CEM Cell Line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Protein kinase CK2: a new view of an old molecular complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Identification of the in vivo phosphorylation sites for acidic-directed kinases in murine mdr1b P-glycoprotein.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Protein kinase CK2 phosphorylates BAD at threonine-117.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Multidrug resistance: molecular mechanisms and clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Protein kinase CK2: structure, regulation and role in cellular decisions of life and death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

One-thousand-and-one substrates of protein kinase CK2?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Protein kinase CK2alpha' is induced by serum as a delayed early gene and cooperates with Ha-ras in fibroblast transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Casein kinase 2: an 'eminence grise' in cellular regulation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Protein kinase CK2: a challenge to canons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2').

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Development and exploitation of CK2 inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Features and potentials of ATP-site directed CK2 inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Validation of protein kinase CK2 as oncological target.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

21 January 2018

Protein kinase CK2 modulates apoptosis induced by resveratrol and epigallocatechin-3-gallate in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein kinase CK2 and its role in cellular proliferation, development and pathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

7 January 2021

based on heuristic

inferred from DOI database lookup

Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

7 January 2021

based on heuristic

inferred from DOI database lookup

Halogenated benzimidazoles and benzotriazoles as selective inhibitors of protein kinases CK I and CK II from Saccharomyces cerevisiae and other sources

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210495

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1210495

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486073%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40135888&oldid=1697807979"